Nomic Bio
Nomic’s core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool.
Year Established: 2017
Stock Ticker:
Exchange:
Locations
Nomic Bio
Somerville MANomic’s core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool.
Nomic Bio
Montreal ONNomic’s core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool.
